Nu-Med Plus (NUMD) Non Operating Income (2023 - 2025)

Nu-Med Plus (NUMD) reported Non Operating Income of -$2857.0 for Q4 2025, down 126.57% on a YoY basis from $10754.3 in Q4 2024, and down 51.08% sequentially from -$1891.0 in Q3 2025.

Nu-Med Plus (NUMD) Non Operating Income (2023 - 2025) Analysis & Trends

Nu-Med Plus (NUMD) has 3 years of Non Operating Income data on file, last reported at -$2857.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income fell 126.57% year-over-year to -$2857.0; the trailing twelve-month figure through Dec 2025 stood at -$7227.0 (down 44.11% YoY), and the FY2025 full-year result was -$7227.0, down 44.14% from the prior year.
  • Non Operating Income declined to -$2857.0 in Q4 2025, from -$1891.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$1233.0 in Q1 2023 to a low of -$2857.0 in Q4 2025.
  • A 3-year average of -$1436.8 and a median of -$1253.5 in 2023 frame the typical range for Non Operating Income.
  • Peak annual rise in Non Operating Income reached 1.12% in 2025, while the deepest fall reached 126.57% in 2025.
  • Tracing NUMD's Non Operating Income over 3 years: stood at -$1260.0 in 2023, then dropped by 0.08% to -$1261.0 in 2024, then plunged by 126.57% to -$2857.0 in 2025.
  • Business Quant data shows NUMD's Non Operating Income at -$2857.0 in Q4 2025, -$1891.0 in Q3 2025, and -$1246.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 62.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -18.60 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Nu-Med Plus 1.67 Mn 1.67 Mn - -2,857.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,857.00
Sep 30, 2025 -1,891.00
Jun 30, 2025 -1,246.00
Mar 31, 2025 -1,233.00
Dec 31, 2024 -1,261.00
Sep 30, 2024 -1,260.00
Jun 30, 2024 -1,247.00
Mar 31, 2024 -1,247.00
Dec 31, 2023 -1,260.00
Sep 30, 2023 -1,260.00
Jun 30, 2023 -1,247.00
Mar 31, 2023 -1,233.00